2025年,由于财政压力和药物成本上升,医疗保险D部分药物计划选择因保险人退出而缩小。 Medicare Part D drug plan choices shrink in 2025 as insurers exit due to financial pressures and rising drug costs.

随着保险公司继续退出市场,医疗保险受益人在2025年面临较少的处方药计划选择,从而在许多地区减少了对注册者的选择。 Medicare beneficiaries face fewer prescription drug plan options in 2025 as insurers continue to exit the market, reducing choices for enrollees in many areas. 这一趋势反映了当前的财政挑战和不断上升的药物成本,促使一些计划停止覆盖。 The trend reflects ongoing financial challenges and rising drug costs, prompting some plans to discontinue coverage. 现有计划的减少可能会影响依赖D部分《医疗保健计划》的老年人和残疾人的获得和可负担性。 This reduction in available plans may impact access and affordability for seniors and disabled individuals relying on Medicare Part D.